BrainStorm Cell Therapeutics Shares Soar on Patent Wins
☀️Trending News BRAINSTORM ($NASDAQ:BCLI): BrainStorm Cell Therapeutics, a global leader in developing autologous cellular therapies in the field of neurodegenerative [...]
FDA and BrainStorm to Discuss Regulatory Path for ALS Therapy
🌥️Trending News BRAINSTORM ($NASDAQ:BCLI): BrainStorm Cell Therapeutics Inc. is a biotechnology company that develops innovative therapies for neurodegenerative diseases such [...]
FDA Panel to Evaluate BrainStorm Cell Therapeutics’ NurOwn Therapy for ALS
🌥️Trending News BRAINSTORM ($NASDAQ:BCLI): BrainStorm Cell Therapeutics is an innovative biotechnology company that is dedicated to developing novel autologous cellular [...]
Brainstorm Cell Therapeutics COO Setboun Set to Depart Amid Filing
Trending News 🌥️ Brainstorm Cell Therapeutics ($NASDAQ:BCLI) is a publicly traded biotechnology company specializing in the development of innovative treatments [...]
BrainStorm Cell Therapeutics Poised for Major Rebound With Upcoming AdCom Meeting For ALS Treatment NurOwn
Trending News ☀️ BRAINSTORM CELL THERAPEUTICS ($NASDAQ:BCLI) is a biotechnology company dedicated to developing innovative autologous cellular therapeutics for the [...]
BrainStorm Cell Therapeutics’ ALS Treatment Fails to Win FDA Approval
Trending News ☀️ BRAINSTORM ($NASDAQ:BCLI): BrainStorm Cell Therapeutics is a biotech company that focuses on cellular therapies. The company announced [...]
BrainStorm Cell Therapeutics Reports Strong Q3 Results, With EPS of $0.53 and Cash Reserves of $7.4M
Trending News ☀️ BRAINSTORM ($NASDAQ:BCLI): BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for [...]
